THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

Anjan Pradhan to Cell Line, Tumor

This is a "connection" page, showing publications Anjan Pradhan has written about Cell Line, Tumor.
Connection Strength

0.935
  1. Pharmacological inhibition of MDA-9/Syntenin blocks breast cancer metastasis through suppression of IL-1?. Proc Natl Acad Sci U S A. 2021 05 25; 118(21).
    View in: PubMed
    Score: 0.141
  2. MDA-7/IL-24 regulates the miRNA processing enzyme DICER through downregulation of MITF. Proc Natl Acad Sci U S A. 2019 03 19; 116(12):5687-5692.
    View in: PubMed
    Score: 0.121
  3. Recombinant MDA-7/IL24 Suppresses Prostate Cancer Bone Metastasis through Downregulation of the Akt/Mcl-1 Pathway. Mol Cancer Ther. 2018 09; 17(9):1951-1960.
    View in: PubMed
    Score: 0.115
  4. mda-7/IL-24 Mediates Cancer Cell-Specific Death via Regulation of miR-221 and the Beclin-1 Axis. Cancer Res. 2017 02 15; 77(4):949-959.
    View in: PubMed
    Score: 0.104
  5. EVI1 up-regulates the stress responsive gene SIRT1 which triggers deacetylation and degradation of EVI1. Biochim Biophys Acta. 2011 Apr-Jun; 1809(4-6):269-75.
    View in: PubMed
    Score: 0.070
  6. Noninvasive therapy of brain cancer using a unique systemic delivery methodology with a cancer terminator virus. J Cell Physiol. 2024 Aug; 239(8):e31302.
    View in: PubMed
    Score: 0.043
  7. MDA-9/Syntenin in the tumor and microenvironment defines prostate cancer bone metastasis. Proc Natl Acad Sci U S A. 2023 Nov 07; 120(45):e2307094120.
    View in: PubMed
    Score: 0.042
  8. A novel computational predictive biological approach distinguishes Integrin ?1 as a salient biomarker for breast cancer chemoresistance. Biochim Biophys Acta Mol Basis Dis. 2023 08; 1869(6):166702.
    View in: PubMed
    Score: 0.040
  9. Engineering T Cells to Express Tumoricidal MDA-7/IL24 Enhances Cancer Immunotherapy. Cancer Res. 2021 05 01; 81(9):2429-2441.
    View in: PubMed
    Score: 0.035
  10. Regulation of neuroblastoma migration, invasion, and in vivo metastasis by genetic and pharmacological manipulation of MDA-9/Syntenin. Oncogene. 2019 10; 38(41):6781-6793.
    View in: PubMed
    Score: 0.031
  11. Suppression of Prostate Cancer Pathogenesis Using an MDA-9/Syntenin (SDCBP) PDZ1 Small-Molecule Inhibitor. Mol Cancer Ther. 2019 11; 18(11):1997-2007.
    View in: PubMed
    Score: 0.031
  12. Regulation of protective autophagy in anoikis-resistant glioma stem cells by SDCBP/MDA-9/Syntenin. Autophagy. 2018; 14(10):1845-1846.
    View in: PubMed
    Score: 0.029
  13. Multi-nucleated cells use ROS to induce breast cancer chemo-resistance in vitro and in vivo. Oncogene. 2018 08; 37(33):4546-4561.
    View in: PubMed
    Score: 0.029
  14. The MDA-9/Syntenin/IGF1R/STAT3 Axis Directs Prostate Cancer Invasion. Cancer Res. 2018 06 01; 78(11):2852-2863.
    View in: PubMed
    Score: 0.028
  15. Novel function of MDA-9/Syntenin (SDCBP) as a regulator of survival and stemness in glioma stem cells. Oncotarget. 2016 Aug 23; 7(34):54102-54119.
    View in: PubMed
    Score: 0.025
  16. Knockout of MDA-9/Syntenin (SDCBP) expression in the microenvironment dampens tumor-supporting inflammation and inhibits melanoma metastasis. Oncotarget. 2016 Jul 26; 7(30):46848-46861.
    View in: PubMed
    Score: 0.025
  17. mda-7/IL-24 Induces Cell Death in Neuroblastoma through a Novel Mechanism Involving AIF and ATM. Cancer Res. 2016 06 15; 76(12):3572-82.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES